4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0000919574-20-004437
Options or other derivatives
- Director acquired 40,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
BRADSHER NEAL C · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-07-01 | Grant or award : show line 1 in the form OPTION TO PURCHASE COMMON SHARES | +40,000 | 40,000 | D |
Loading xslF345X03/ownership.xml…